ARIS
DXCM icon

Advanced Research Investment Solutions’s DexCom DXCM Stock Holding History

Advanced Research Investment Solutions’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-60
Closed -$8K – 208
2021
Q4 		$8K Buy
+60
New +$8.62K ﹤0.01% 154

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Advanced Research Investment Solutions's DXCM Position: Q1 2022 in Review

Advanced Research Investment Solutions sold out of DexCom (DXCM) in Q1 2022, closing a stake of 60 shares — an estimated $8K sold.

Advanced Research Investment Solutions first reported a position in DXCM in Q4 2021 and held it in 1 quarter. The position peaked at $8K in Q4 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Advanced Research Investment Solutions reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Advanced Research Investment Solutions sold 60 DexCom shares in Q1 2022, an estimated $8K.
  • Advanced Research Investment Solutions first reported a position in DexCom in Q4 2021 and held it in 1 quarter.
  • Advanced Research Investment Solutions's DexCom position peaked at $8K in Q4 2021.
  • 861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Advanced Research Investment Solutions's 13F filing for Q1 2022, filed 10 May 2022.